Infection After Implant-based Breast Reconstruction

A Systemic Review and Analysis of Factors and Outcomes in Breast Reconstruction

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06187649

Enrollment

5000

Registered

2024-01-02

Start date

2015-01-01

Completion date

2024-12-31

Last updated

2024-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Implant Infection

Brief summary

Infections following postmastectomy breast reconstruction can compromise surgical outcomes and lead to significant morbidity. The aim of this study was to determine factors associated with infection following two-stage implant-based reconstruction.

Interventions

PROCEDUREbreast reconstruction

breast expander/implant insertion for breast reconstruction following mastectomy

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients who received implant-based breast reconstruction following mastectomy between 2015 and 2020 in Seoul National University Hospital

Exclusion criteria

* Patients who received flap surgery simultaneously with implant insertion

Design outcomes

Primary

Measure	Time frame	Description
Infection	7 years	Number of patients who developed requiring hospitalization-requiring infection

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026